מדינה: ישראל
שפה: עברית
מקור: Ministry of Health
HEPATITIS B IMMUNOGLOBULIN
TZAMAL BIO-PHARMA LTD
J06BB04
תמיסה להזרקה
HEPATITIS B IMMUNOGLOBULIN 312 IU/ML
תוך-שרירי, תוך-ורידי
מרשם נדרש
EMERGENT BIOSOLUTION CANADA INC., CANADA
HEPATITIS B IMMUNOGLOBULIN
HEPATITIS B IMMUNOGLOBULIN
Prevention of hepatitis B recurrence following liver transplantation : Hepagam B is indicated for the prevetion of hepatitis B recurrence following liver transplantation in HBsAg-positive liver transplant patients. Hepagam B should be administered intravenously for this indication.Postexposure prophylaxis : Hepagam B is indicated for the treatment of acute exposure to blood containing HBsAg perinatal exposure of infants born to HBsAg-positive mothers sexual exposure to HBsAg-positive persons and household exposure to persons with acute HBV infection in the following settings: Acute exposure to blood containing HBsAg Following either parenteral exposure (needlestick bite sharps) direct mucous membrane contact (accidental splash) or oral ingestion (pipetting accident) involving HBsAg - positive materials such as blood plasma or serum. Perinatal exposure of infants born to HBsAg-positive mothers Infants born to mothers positive for HBsAg with or without HBeAg. Perinatal exposure of infants born to HBsAg-positive
התרופה תינתן לטיפול בכל אחד מאלה: א. מניעה לאחר חשיפה לוירוס HBV. ב. ילודים לאמהות נשאיות HBV. ג. חיסון פסיבי למניעת זיהום חוזר ב-HBV לאחר השתלת כבד.
2014-03-31